SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Centocor ( CNTO )
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
965 13 0 CNTO
Emcee:  PawPr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
665 I found this great post on the Yahoo thread. Good luck everyone. Modano : ) Modano-5/27/1998
664 As a correction to my previous post, I understand that the stock will not be trModano-5/27/1998
663 It looks like tomorrow will be a telling day for CNTO. They said this afternooModano-5/27/1998
662 SPECTRAL'S CARDIAC STATUS(TM) TROPONIN I IS CHOSEN TO PARTICIPATE --------Donaldm-5/12/1998
661 BancAmerica Robertson Stephens Initiates Coverage on Centocor With a Buy RatingALTERN8-5/12/1998
660 Monday is the day for earnings - not much expected given all cross-currents: - Robohogs-4/18/1998
659 Does anyone have access to a list of site that are in the Avakine clinical triaSleepman-4/16/1998
658 Bruce: Well said....my understanding! Thought your post should be repeated: FNS-4/15/1998
657 The lymphoma concern was for rheumatoid arthritis patients, and to my knowledgePawPr-4/15/1998
656 My impression is that Crohn's patients have normal life span, similar life SG-4/15/1998
655 Yes and no. Comment #653 echos my view. In many ways, patients with autoimmune PawPr-4/15/1998
654 Don't misunderstand me...this drug performs miracles when it comes to healipuborectalis-4/15/1998
653 Stephen: I am not an MD so I can not make any medical judgements. UnfortunateFNS-4/14/1998
652 I'd be careful in assuming that Rheumatoid patients have a greater incidencpuborectalis-4/14/1998
651 A few rheumatoid arthritis patients in one of the Avakine studies developed lymPawPr-4/14/1998
650 Check out the Merk thread. Much info (from post #692): <<A FDA advisoryFNS-4/14/1998
649 <<Merck & Co.'s (MRK) anti-clotting heart drug, Aggrastat, was ovFNS-4/14/1998
648 Where was there a mention of possible association with lymphoma for Avakine? SSG-4/10/1998
647 I agree that the Crohn's disease market is small, but approval will send a PawPr-4/9/1998
646 Bruce, I think that the most important upcoming events for CNTO are ReoPro/RetHong-Lee Yu-4/9/1998
645 Bruce: Thanks for your input. I think we agree on the potential negative expoFNS-4/9/1998
644 I've continued to follow CNTO although, as I've previously indicated, IPawPr-4/9/1998
643 Mighty quiet thread! Wake up! Couple of things to think about: - CNTO shouldFNS-4/9/1998
642 The Avakine news doesn't appear to be that favorable! CNTO stock price tooFNS-4/6/1998
641biz.yahoo.comDZOO-4/6/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News